Elevated plasma Clara cell secretory protein concentration is associated with high-grade primary graft dysfunction

American Journal of Transplantation

Volumn 11, Issue 3, 2011, Pages 561-567

  Diamond, Joshua M ^a   Kawut, S M ^a   Lederer, D J ^b   Ahya, V N ^a   Kohl, B ^a   Sonett, J ^b   Palmer, S M ^c   Crespo, M ^d   Wille, K ^e   Lama, V N ^f   Shah, P D ^g   Orens, J ^h   Bhorade, S ⁱ   Weinacker, A ^j   Demissie, E ^a   Bellamy, S ^a   Christie, J D ^a   Ware, L B ^g  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e University of Alabama at Birmingham   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

^g VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF CHICAGO   (United States)

^j STANFORD UNIVERSITY   (United States)

more..

Author keywords

Clara cell; Lung transplantation; Primary graft dysfunction

Indexed keywords

CLARA CELL PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GRAFT RECIPIENT; HUMAN; ISCHEMIA; LUNG ALVEOLUS; LUNG ISCHEMIA; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIMARY GRAFT DYSFUNCTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REPERFUSION INJURY; RESPIRATORY EPITHELIUM;

ADULT; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PRIMARY GRAFT DYSFUNCTION; PROGNOSIS; PROSPECTIVE STUDIES; UTEROGLOBIN;

EID: 79951996027     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03431.x     Document Type: Article

References (42)

1. Christie JD, Edwards LB, Aurora P et al. The Registry of the International Society for Heart and Lung Transplantation: Twentysixth official adult lung and heart-lung transplantation report-2009. J Heart Lung Transplant 2009; 28: 1031-1049.
2. Taylor DO, Stehlik J, Edwards LB et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009. J Heart Lung Transplant 2009; 28: 1007-1022.
3. Arcasoy SM, Fisher A, Hachem RR, Scavuzzo M, Ware LB. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part V: Predictors and outcomes. J Heart Lung Transplant 2005; 24: 1483-1488. (Pubitemid 41396442)
4. Christie JD, Bavaria JE, Palevsky HI et al. Primary graft failure following lung transplantation. Chest 1998; 114: 51-60. (Pubitemid 28337361)
5. Christie JD, Kotloff RM, Ahya VN et al. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 2005; 171: 1312-1316. (Pubitemid 40740741)
6. Christie JD, Kotloff RM, Pochettino A et al. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003; 124: 1232-1241. (Pubitemid 37290031)
7. Lee JC, Christie JD. Primary graft dysfunction. Proc Am Thorac Soc 2009; 6: 39-46.
8. Christie JD, Sager JS, Kimmel SE et al. Impact of primary graft failure on outcomes following lung transplantation. Chest 2005; 127: 161-165. (Pubitemid 41724571)
9. Bharat A, Kuo E, Steward N et al. Immunological link between primary graft dysfunction and chronic lung allograft rejection. Ann Thorac Surg 2008; 86:189-195; discussion 196-187.
10. Bharat A, Narayanan K, Street T et al. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection. Transplantation 2007; 83: 150-158. (Pubitemid 46185205)
11. Daud SA, Yusen RD, Meyers BF et al. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2007; 175: 507-513. (Pubitemid 46354255)
12. Bobadilla JL, Love RB, Jankowska-Gan E et al. Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation. Am J Respir Crit Care Med 2008; 177: 660-668. (Pubitemid 351442174)
13. Christie JD, Robinson N, Ware LB et al. Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction. Am J Respir Crit Care Med 2007; 175: 69-74. (Pubitemid 46105311)
14. Christie JD, Shah CV, Kawut SM et al. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. Am J Respir Crit Care Med 2009; 180: 1010-1015.
15. Covarrubias M, Ware LB, Kawut SM et al. Plasma intercellular adhesion molecule-1 and von Willebrand factor in primary graft dysfunction after lung transplantation. Am J Transplant 2007; 7: 2573-2578. (Pubitemid 47561623)
16. Hoffman SA, Wang L, Shah CV et al. Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation. Am J Transplant 2009; 9: 389-396.
17. Iwata T, Philipovskiy A, Fisher AJ et al. Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction. J Immunol 2008; 181: 5738-5747.
18. Krenn K, Klepetko W, Taghavi S, Lang G, Schneider B, Aharinejad S. Recipient vascular endothelial growth factor serum levels predict primary lung graft dysfunction. Am J Transplant 2007; 7: 700-706. (Pubitemid 46376456)
19. Kawut SM, Okun J, Shimbo D et al. Soluble p-selectin and the risk of primary graft dysfunction after lung transplantation. Chest 2009; 136: 237-244.
20. Broeckaert F, Clippe A, Knoops B, Hermans C, Bernard A. Clara cell secretory protein (CC16): Features as a peripheral lung biomarker. Ann N Y Acad Sci 2000; 923: 68-77. (Pubitemid 32050206)
21. Kropski JA, Fremont RD, Calfee CS, Ware LB. Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury. Chest 2009; 135: 1440-1447.
22. Mattsson J, Remberger M, Andersson O, Sundberg B, Nord M. Decreased serum levels of Clara cell secretory protein (CC16) are associated with bronchiolitis obliterans and may permit early diagnosis in patients after allogeneic stem-cell transplantation. Transplantation 2005; 79: 1411-1416. (Pubitemid 40734806)
23. Nord M, Schubert K, Cassel TN, Andersson O, Riise GC. Decreased serum and bronchoalveolar lavage levels of Clara cell secretory protein (CC16) is associated with bronchiolitis obliterans syndrome and airway neutrophilia in lung transplant recipients. Transplantation 2002; 73: 1264-1269. (Pubitemid 34454273)
24. Bernard A, Hermans C, Van Houte G. Transient increase of serum Clara cell protein (CC16) after exposure to smoke. Occup Environ Med 1997; 54: 63-65. (Pubitemid 27076896)
25. Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005; 24: 1454-1459. (Pubitemid 41396439)
26. King RC, Binns OA, Rodriguez F et al. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 2000; 69: 1681-1685. (Pubitemid 30445505)
27. Thabut G, Mal H, Cerrina J et al. Graft ischemic time and outcome of lung transplantation: A multicenter analysis. Am J Respir Crit Care Med 2005; 171: 786-791. (Pubitemid 40471151)
28. Maldonado G, Greenland S. Simulation study of confounderselection strategies. Am J Epidemiol 1993; 138: 923-936.
29. Arsalane K, Broeckaert F, Knoops B, Wiedig M, Toubeau G, Bernard A. Clara cell specific protein (CC16) expression after acute lung inflammation induced by intratracheal lipopolysaccharide administration. Am J Respir Crit Care Med 2000; 161: 1624-1630. (Pubitemid 30329039)
30. Determann RM, Millo JL, Waddy S, Lutter R, Garrard CS, Schultz MJ. Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilator-associated pneumonia: A retrospective observational study. BMC Pulm Med 2009; 9: 49-58.
31. Andersson O, Nordlund-Moller L, Barnes HJ, Lund J. Heterologous expression of human uteroglobin/polychlorinated biphenyl-binding protein. Determination of ligand binding parameters and mechanism of phospholipase A2 inhibition in vitro. J Biol Chem 1994; 269:19081-19087.
32. Lesur O, Bernard A, Arsalane K et al. Clara cell protein (CC-16) induces a phospholipase A2-mediated inhibition of fibroblast migration in vitro. Am J Respir Crit Care Med 1995; 152: 290-297.
33. Yao XL, Levine SJ, Cowan MJ, Logun C, Shelhamer JH. Tumor necrosis factor-alpha stimulates human Clara cell secretory protein production by human airway epithelial cells. Am J Respir Cell Mol Biol 1998; 19: 629-635. (Pubitemid 128354245)
34. Greene KE, King TE Jr., Kuroki Y et al. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur Respir J 2002; 19: 439-446. (Pubitemid 34256957)
35. Reichenberger F, Schauer J, Kellner K, Sack U, Stiehl P, Winkler J. Different expression of endothelin in the bronchoalveolar lavage in patients with pulmonary diseases. Lung 2001; 179: 163-174.
36. Rosas IO, Richards TJ, Konishi K et al. MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med 2008; 5:e93.
37. Huang HJ, Yusen RD, Meyers BF et al. Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome. Am J Transplant 2008; 8: 2454-2462.
38. Whitson BA, Prekker ME, Herrington CS et al. Primary graft dysfunction and long-term pulmonary function after lung transplantation. J Heart Lung Transplant 2007; 26: 1004-1011. (Pubitemid 47494652)
39. Broeckaert F, Bernard A. Clara cell secretory protein (CC16): Characteristics and perspectives as lung peripheral biomarker. Clin Exp Allergy 2000; 30: 469-475. (Pubitemid 30253184)
40. Behr J, Maier K, Braun B, Schwaiblmair M, Vogelmeier C. Evidence for oxidative stress in bronchiolitis obliterans syndrome after lung and heart-lung trnsplantation: The Munich Lung Transplant Group. Transplantation 2000; 69: 1856-1860. (Pubitemid 30340345)
41. Hirsch J, Elssner A, Mazur G et al. Bronchiolitis obliterans syndrome after (heart-) lung transplantation. Am J Crit Care Med 1999; 160: 1640-1646.
42. Ware LB, Golden JA, Finkbeiner WE, Matthay MA. Alveolar epithelial fluid transport capacity in reperfusion lung injury after lung transplantation. Am J Respir Crit Care Med 1999; 159: 980-988. (Pubitemid 29137805)